User profiles for Eugen Feist

Eugen Feist

Professor
Verified email at helios-gesundheit.de
Cited by 10210

Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus

M Odendahl, A Jacobi, A Hansen, E Feist… - The Journal of …, 2000 - journals.aai.org
In patients with active systemic lupus erythematosus (SLE), a marked B lymphocytopenia
was identified that affected CD19+/CD27− naive B cells more than CD19+/CD27+ memory B …

[PDF][PDF] European S3-guidelines on the systemic treatment of psoriasis vulgaris-update 2015-short version-EDF in cooperation with EADV and IPC

…, E Dauden, EM de Jong, E Feist… - Journal of the …, 2015 - publicatio.bibl.u-szeged.hu
This is an executive summary of all consented recommendations of the European Psoriasis
Guidelines–Update 2015. The long version of this guideline is available online as …

Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis

…, G Fredenhagen, W Berg, E Feist… - Arthritis & …, 2007 - Wiley Online Library
Objective Modification of antigens represents a trigger for the generation of autoantibodies.
In the pathogenesis of rheumatoid arthritis (RA), citrullination of proteins has been shown to …

Diminished peripheral blood memory B cells and accumulation of memory B cells in the salivary glands of patients with Sjögren's syndrome

…, M Odendahl, K Reiter, AM Jacobi, E Feist… - Arthritis & …, 2002 - Wiley Online Library
Objective. To delineate the mechanism of the abnormalities in B cell biology found in
patients with primary Sjögren’s syndrome (SS). Methods. The distribution of peripheral B cell …

Emerging cell and cytokine targets in rheumatoid arthritis

GR Burmester, E Feist, T Dörner - Nature Reviews Rheumatology, 2014 - nature.com
Despite major progress in the treatment of rheumatoid arthritis (RA), strong unmet medical
need remains, as only a minor proportion of patients reach sustained clinical remission. New …

Rheumatoid factor revisited

T Dörner, K Egerer, E Feist… - Current opinion in …, 2004 - journals.lww.com
In patients with rheumatoid arthritis, the induction of rheumatoid factors can be taken as an
indicator of severe disease with a striking involvement of B cell activation. Very recent clinical …

[HTML][HTML] Mechanisms, biomarkers and targets for adult-onset Still's disease

E Feist, S Mitrovic, B Fautrel - Nature Reviews Rheumatology, 2018 - nature.com
Adult-onset Still’s disease (AoSD) is a rare but clinically well-known, polygenic, systemic
autoinflammatory disease. Owing to its sporadic appearance in all adult age groups with …

Open-label, multicentre, dose-escalating phase II clinical trial on the safety and efficacy of tadekinig alfa (IL-18BP) in adult-onset Still's disease

C Gabay, B Fautrel, J Rech, F Spertini, E Feist… - Annals of the …, 2018 - ard.bmj.com
Objectives Adult-onset Still’s disease (AOSD) is a rare systemic autoinflammatory disease;
its management is largely empirical. This is the first clinical study to determine if interleukin (IL)…

A phase III, randomized, controlled trial of apremilast in patients with psoriatic arthritis: results of the PALACE 2 trial

…, F Van den Bosch, H Marzo-Ortega, E Feist… - The Journal of …, 2016 - jrheum.org
Objective. Apremilast, an oral phosphodiesterase 4 inhibitor, downregulates intracellular
inflammatory mediator synthesis by elevating cyclic adenosine monophosphate levels. The …

Tenosynovitis of the flexor tendons of the hand detected by MRI: an early indicator of rheumatoid arthritis

I Eshed, E Feist, CE Althoff, B Hamm, E Konen… - …, 2009 - academic.oup.com
Objective. To evaluate the potential of MRI of finger and wrist joints for diagnosing early RA.
MRI was evaluated as a stand-alone tool and in combination with ACR criteria and serum …